|
Aug 29
|
The most expensive drugs in the US
|
|
Aug 28
|
Is BioMarin (BMRN) a Solid Growth Stock? 3 Reasons to Think "Yes"
|
|
Aug 28
|
Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term
|
|
Jul 26
|
The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen Agenus and BioMarin Pharmaceutical
|
|
Jul 25
|
FDA agrees wider use of BioMarin’s BRINEURA for CLN2
|
|
Jul 24
|
U.S. Food and Drug Administration Approves BioMarin's BRINEURA® (cerliponase alfa) for Children Under 3 Years with CLN2 Disease
|
|
Jul 24
|
Why BioMarin (BMRN) is Poised to Beat Earnings Estimates Again
|
|
Jul 23
|
Analysts Estimate Repligen (RGEN) to Report a Decline in Earnings: What to Look Out for
|
|
Jul 23
|
BioMarin to Host Second Quarter 2024 Financial Results Conference Call and Webcast on Monday, August 5, 2024, at 4:30pm ET
|
|
Jul 22
|
BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: What to Know Ahead of Q2 Release
|
|
Jul 18
|
Xoma (XOMA) Surges 6.4%: Is This an Indication of Further Gains?
|
|
Jun 23
|
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Could Be 41% Below Their Intrinsic Value Estimate
|
|
Jun 20
|
Should You Hold BioMarin Pharmaceutical (BMRN) Despite Setback?
|
|
Jun 18
|
Mirum Pharmaceuticals (MIRM) Soars 27.3%: Is Further Upside Left in the Stock?
|
|
May 27
|
BioMarin Pharmaceutical (NASDAQ:BMRN) shareholders have endured a 15% loss from investing in the stock a year ago
|
|
May 24
|
BioMarin (BMRN) Down 7.6% Since Last Earnings Report: Can It Rebound?
|
|
May 18
|
4 Incomparable Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
|
|
May 15
|
Novo Holdings buys stake in life sciences tools company; BioMarin lays off 170
|
|
May 9
|
The 3 Best Biotech Stocks to Buy in May 2024
|
|
May 8
|
BioMarin to Present at the BofA Securities 2024 Health Care Conference on Wednesday, May 15 at 10:00am PT / 1:00pm ET, in Las Vegas, NV
|